Dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 to 17 [ID5104]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 29 May 2024
DCVax-L for treating glioblastoma [ID836]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over TS ID 11974Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC